Extended-Release Opioid Gets FDA OK - in Neurology, Pain Management from MedPage Today
Medical News: Extended-Release Opioid Gets FDA OK - in Neurology, Pain Management from MedPage Today
"Tapentadol was also well-tolerated, the company said. Opioids can cause a number of side effects, including constipation, that may cause patients to discontinue their use.
A 2010 phase III study comparing the drug to oxycodone in patients with painful knee osteoarthritis found that tapentadol provided effective pain relief with fewer of the gastrointestinal side effects seen with oxycodone"
0 comments:
Post a Comment